Table 2.
Variables | n = 84 |
Age, y | 63 (24–89) |
Years since RA diagnosis | 13 (0–45) |
HAQ-DI | 0.11 (0–2.7) |
DAS28-ESR | 2.8 (0.9–7.1) |
DAS28-ESR moderate-severe (>3.2), n (%) | 31 (36.9) |
Rheumatoid cachexia, n (%) | 12 (14.3) |
Treatment | |
Biological drugs, n (%) | 5 (6) |
Glucocorticoids, n (%) | 71 (85.5) |
Dose of glucocorticoids, mg/day | 5 (0–17.5) |
DMARD, n (%) | 80 (96.4) |
NSAID, n (%) | 78 (95.1) |
Laboratory | |
∗CRP, mg/dL | 10.2 (0.3–219) |
ESR, mm/h | 20.5 (1–64) |
Myostatin, ng/mL | 9 (1.2–140) |